Medtronic

By Heather Mack December 7, 2016
Medical device maker Medtronic has teamed up with Fitbit to integrate physical activity data with blood glucose levels into one streamlined application.  People living with type 2 diabetes who use Medtronic's iPro2 continuous glucose monitoring system and its companion app, iPro2 myLog, will now be able to have their Fitbit data automatically synced to the app, enabling them to easily see the...
By Jonah Comstock October 25, 2016
More than a year after Medtronic released its MiniMed Connect system, which connects an insulin pump and affiliated CGM to a smartphone app, the company has launched an Android version of the MiniMed Connect app. "For people with diabetes, constantly monitoring blood sugar levels can be cumbersome and anything but discreet," Annette Brüls, president of the diabetes service and solutions business...
By Heather Mack October 7, 2016
As we take a look at the devices that received FDA clearance in 2016's third quarter, we're also considering that the last few months have been a time of change at the Food and Drug Administration, as regulators are beginning to make updates in their system to accomodate all the digital health tools we're seeing.  In June, the FDA offered up a draft guidance document designed to help medical...
By Jonah Comstock September 29, 2016
Medtronic came out with two pieces of news yesterday around its connected diabetes efforts: an FDA clearance for a hybrid closed loop insulin delivery system and the first test cohort of its Sugar.IQ app, created in collaboration with IBM Watson. The FDA approval of Medtronic’s MiniMed 670G hybrid closed looped system was announced by the FDA itself, as it’s the first automated insulin delivery...
By Jonah Comstock August 11, 2016
Ascensia Diabetes Care, a new business unit created this year when Panasonic Healthcare Holdings acquired Bayer Diabetes Care, has announced the launch and FDA 510(k) clearance of its Contour Next Link blood glucose monitor.  Ascensia makes a line of connected and non-connected fingerstick glucometers. The Contour Next Link is a version that sends data wirelessly to Medtronic's MiniMed 630G...
By Heather Mack July 25, 2016
Israel-based DreaMed Diabetes announced this week that it has raised $3.3 million from Norma Investments, Russian businessman Roman Abramovich and one other unnamed angel. The funds will mainly be used for further development of DreaMed’s Advisor, the company's decision support software that can be licensed and embedded into partners' diabetes management platforms. For example, in February, the...
By Jonah Comstock July 19, 2016
Medtronic has received a CE Mark for its Guardian Connect mobile continuous glucose monitor (CGM) and app. The company will begin selling the system in select countries in Europe, Asia, and Latin America in Q2 2017 and expects to receive FDA clearance to launch the device in the US around that same time. The Dublin, Ireland-based company already has an FDA and CE cleared connected CGM called...
By Jonah Comstock June 13, 2016
A number of pieces of interesting health tech news came out of the 76th Annual Scientific Sessions of the American Diabetes Association, held this weekend in New Orleans. Here’s a roundup of the highlights. Updated 6/15/2016 to include some more news items. IBM’s Medtronic partnership gets a name. Information has been trickling out about Medtronic’s collaboration with IBM Watson Health that was...
By Brian Dolan June 9, 2016
In 2012 The Wall Street Journal published a story that quoted a big medical device company spokesperson explaining that they couldn't provide patients the medical device data gathered by implanted devices inside their own bodies because regulators wouldn't allow it. "Medtronic says federal rules prohibit giving Ms. Hubbard's data to anyone but her doctor and hospital. 'Our customers are...
By Jonah Comstock May 25, 2016
Medtronic announced that it will work with Qualcomm Life to develop a new generation of smaller, affordable continuous glucose monitors (CGMs) for people with Type 2 diabetes, the companies announced today. Currently, CGM devices are mostly prescribed for people with Type 1 diabetes, while those with Type 2 are more likely to use discrete finger-prick glucometers. However, this new partnership...